Phonak Audeo R Infinio 90 vs Vivtone Xpure Hearing Aid

The Phonak Audeo R Infinio 90 is a premium prescription behind-the-ear hearing aid released in 2024, priced at $4,996. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #18 among 39 prescription hearing aids tested. Speech clarity is a standout strength in our testing. Speech in quiet scored 4.4/5, a strong result that sits 1.01 points above the category average. Speech in noise performance is more mixed at 2.5/5—above the category average by 0.37 points, but only moderate in absolute terms. This pattern suggests the Infinio 90 excels in calmer listening environments while offering incremental benefits in challenging noise. Streaming music quality impressed at 4.0/5, a strong score that lands 1.24 points above category average. Feedback handling scored 4.2/5, which is strong in absolute terms though 0.52 points below the category average. Own-voice comfort was mixed at 2.2/5, falling 0.50 points below average—something to discuss with your hearing care provider if natural voice quality is a priority. The Infinio 90 competes in a crowded premium segment. At this price point, alternatives like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieved higher overall scores in our testing. Buyers seeking Phonak's ecosystem and strong speech-in-quiet performance may find the Infinio 90 appealing, though those prioritizing noise performance or own-voice comfort should compare options carefully with their provider.

The Vivtone Xpure is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.1/5 in HearAdvisor's lab testing. This places it in the lower tier of the OTC category, ranking #57 of 65 devices tested. The Xpure demonstrates a notably uneven performance profile. Its standout strength is music streaming, scoring an excellent 4.4/5—a remarkable 2.48 points above the category average. This makes it one of the better choices for users who prioritize audio entertainment through their hearing aids. Speech in quiet performs just slightly above category average at 2.9/5, though this remains mixed in absolute terms. However, the device shows significant weaknesses in several areas. Own-voice comfort scores a low 0.8/5, falling 1.71 points below the category average—a notable concern for users sensitive to how their own voice sounds. Speech in noise at 1.2/5 sits below the category average, and feedback handling, while solid at 3.3/5, still falls 1.24 points below what typical OTC devices achieve. The Xpure improves meaningfully with professional tuning, jumping from a normalized Initial Score of 3.0/5 to a Tuned Score of 3.5/5. Shoppers prioritizing music streaming may find value here, but those seeking balanced speech performance or natural own-voice quality should consider alternatives like the Linner Nova Earbud or Nuheara IQBuds Max, which offer higher overall scores at lower prices.